Advanced search
Publication Cover
Clinical Epidemiology Volume 16, 2024 - Issue
Submit an article Journal homepage
161
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States

Vincent Lo Re III1 Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;2 Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7955-0600View further author information
ORCID Icon,
Noelle M Cocoros3 Department of Population Medicine, Harvard Medical School, Boston, MA, USA;4 Harvard Pilgrim Healthcare Institute, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-7090-2761View further author information
ORCID Icon,
Rebecca A Hubbard2 Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0003-0879-0994View further author information
ORCID Icon,
Sarah K Dutcher5 Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USAORCID Iconhttps://orcid.org/0000-0003-0574-2890View further author information
ORCID Icon,
Craig W Newcomb2 Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAView further author information
,
John G Connolly3 Department of Population Medicine, Harvard Medical School, Boston, MA, USA;4 Harvard Pilgrim Healthcare Institute, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0003-1916-557XView further author information
ORCID Icon,
Silvia Perez-Vilar5 Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USAORCID Iconhttps://orcid.org/0000-0003-1272-1502View further author information
ORCID Icon,
Dena M Carbonari2 Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0003-0310-270XView further author information
ORCID Icon,
Maria E Kempner3 Department of Population Medicine, Harvard Medical School, Boston, MA, USA;4 Harvard Pilgrim Healthcare Institute, Boston, MA, USAView further author information
,
José J Hernández-Muñoz5 Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USAORCID Iconhttps://orcid.org/0000-0002-2553-3159View further author information
ORCID Icon,
Andrew B Petrone3 Department of Population Medicine, Harvard Medical School, Boston, MA, USA;4 Harvard Pilgrim Healthcare Institute, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-8413-6236View further author information
ORCID Icon,
Allyson M Pishko6 Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0001-9997-454XView further author information
ORCID Icon,
Meighan E Rogers Driscoll3 Department of Population Medicine, Harvard Medical School, Boston, MA, USA;4 Harvard Pilgrim Healthcare Institute, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0003-1371-9658View further author information
ORCID Icon,
James T Brash7 IQVIA, Real World Solutions, Brighton, UKView further author information
,
Sean Burnett8 Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada;9 Therapeutics Initiative, University of British Columbia, Vancouver, British Columbia, CanadaView further author information
,
Catherine Cohet10 Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0002-0022-7251View further author information
ORCID Icon,
Matthew Dahl8 Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada;11 Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, CanadaView further author information
,
Terese A DeFor12 HealthPartners Institute, Bloomington, MN, USAView further author information
,
Antonella Delmestri13 Pharmaco- and Device Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UKORCID Iconhttps://orcid.org/0000-0003-0388-3403View further author information
ORCID Icon,
Djeneba Audrey Djibo14 CVS Health, Blue Bell, PA, USAORCID Iconhttps://orcid.org/0000-0003-3378-0691View further author information
ORCID Icon,
Talita Duarte-Salles15 Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain;16 Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0002-8274-0357View further author information
ORCID Icon,
Laura B Harrington17 Kaiser Permanente Washington Health Research Institute, Seattle, WA, USAORCID Iconhttps://orcid.org/0000-0001-5951-8291View further author information
ORCID Icon,
Melissa Kampman18 Health Canada, Ottawa, Ontario, CanadaView further author information
,
Jennifer L Kuntz19 Kaiser Permanente Northwest Center for Health Research, Portland, OR, USAORCID Iconhttps://orcid.org/0000-0002-0017-6853View further author information
ORCID Icon,
Xavier Kurz10 Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0002-9838-7754View further author information
ORCID Icon,
Núria Mercadé-Besora15 Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, SpainORCID Iconhttps://orcid.org/0009-0006-7948-3747View further author information
ORCID Icon,
Pamala A Pawloski12 HealthPartners Institute, Bloomington, MN, USAORCID Iconhttps://orcid.org/0000-0002-1005-5764View further author information
ORCID Icon,
Peter R Rijnbeek16 Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0003-0621-1979View further author information
ORCID Icon,
Sarah Seager7 IQVIA, Real World Solutions, Brighton, UKView further author information
,
Claudia A Steiner20 Kaiser Permanente Colorado Institute for Health Research, Aurora, CO, USA;21 Colorado Permanente Medical Group, Denver, CO, USAView further author information
,
Katia Verhamme16 Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0001-8162-4904View further author information
ORCID Icon,
Fangyun Wu8 Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada;22 ICES, Toronto, Ontario, CanadaView further author information
,
Yunping Zhou23 Humana Healthcare Research, Inc., Louisville, KY, USAView further author information
,
Edward Burn13 Pharmaco- and Device Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UKORCID Iconhttps://orcid.org/0000-0002-9286-1128View further author information
ORCID Icon,
J Michael Paterson8 Canadian Network for Observational Drug Effect Studies (CNODES), Toronto, Ontario, Canada;22 ICES, Toronto, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0001-5995-1714View further author information
ORCID Icon &
Daniel Prieto-Alhambra13 Pharmaco- and Device Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK;16 Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0002-3950-6346View further author information
ORCID Icon show all
Pages 71-89 | Received 09 Nov 2023, Accepted 23 Jan 2024, Published online: 10 Feb 2024

References

  • Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575
  • Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489–500. doi:10.1182/blood.2020006520
  • Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–1742. doi:10.1111/jth.14850
  • Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020;120(6):998–1000. doi:10.1055/s-0040-1714350
  • Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–2040. doi:10.1182/blood.2020006000
  • Burn E, Duarte-Salles T, Fernandez-Bertolin S, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. 2022;22(8):1142–1152. doi:10.1016/S1473-3099(22)00223-7
  • Lo Re V 3rd, Dutcher SK, Connolly JG, et al. Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients. JAMA. 2022;328(7):637–651. doi:10.1001/jama.2022.13072
  • International Coalition of Medicines Regulatory Authorities. COVID-19; 2023. Available from: https://www.icmra.info/drupal/en/covid-19. Accessed July 19, 2023.
  • Suissa S, Henry D, Caetano P, et al. CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med. 2012;6(4):e134–140. doi:10.1038/clpt.1985.188
  • Wolf A, Dedman D, Campbell J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. 2019;48(6):1740–1740g. doi:10.1093/ije/dyz034
  • Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459–466. doi:10.5414/CP203320
  • Agostoni E, Barbanti P, Frediani F, et al. Real-world insights on the management of migraine patients: an Italian nationwide study. Curr Med Res Opin. 2019;35(9):1545–1554. doi:10.1080/03007995.2019.1602032
  • de Ridder MAJ, de Wilde M, de Ben C, et al. Data resource profile: the Integrated Primary Care Information (IPCI) database, the Netherlands. Int J Epidemiol. 2022;51(6):e314–e323. doi:10.1093/ije/dyac026
  • Recalde M, Rodriguez C, Burn E, et al. Data resource profile: the Information System for Research in Primary Care (SIDIAP). Int J Epidemiol. 2022;51(6):e324–e336. doi:10.1093/ije/dyac068
  • Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1(S1):23–31. doi:10.1002/pds.2336
  • Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54–60. doi:10.1136/amiajnl-2011-000376
  • Ministerio de Sanidad. Hospital discharge records in the National Health System; 2023. Avaialable from: https://www.sanidad.gob.es/en/estadEstudios/estadisticas/cmbdhome.htm. Accessed July 19, 2023.
  • Cocoros NM, Fuller CC, Adimadhyam S, et al. A COVID-19-ready public health surveillance system: the Food and Drug Administration’s Sentinel System. Pharmacoepidemiol Drug Saf. 2021;30(7):827–837. doi:10.1002/pds.5240
  • Rosati K, Jorgensen N, Soliz M, Evans BJ Sentinel Initiative principles and policies: HIPAA and Common Rule compliance in the Sentinel Initiative; 2021. Available from: https://www.sentinelinitiative.org/sites/default/files/communications/publications-presentations/HIPAA-Common-Rule-Compliance-in-Sentinel-Initiative.pdf. Accessed October 31, 2021.
  • Basic HHS policy for protection of human research subjects, 45 CFR §46.102(l)(2); 2021. Available from: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46/subpart-A#46.102. Accessed on November 2, 2021.
  • Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461–1467. doi:10.1038/s41591-022-01840-0
  • Lo Re V, Dutcher SK, Connolly JG, et al. Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. BMJ Med. 2023;2(1):e000421.
  • Haynes K. Preparing for COVID-19 vaccine safety surveillance: a United States perspective. Pharmacoepidemiol Drug Saf. 2020;29(12):1529–1531. doi:10.1002/pds.5142
  • Lo Re V, Klungel OH, Chan KA, Panozzo CA, Zhou W, Winterstein AG. Global covid-19 vaccine rollout and safety surveillance-how to keep pace. BMJ. 2021;373:n1416. doi:10.1136/bmj.n1416
  • Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf. 2008;17(1):20–26. doi:10.1002/pds.1518
  • Wahl PM, Rodgers K, Schneeweiss S, et al. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf. 2010;19(6):596–603. doi:10.1002/pds.1924
  • Cutrona SL, Toh S, Iyer A, et al. Validation of acute myocardial infarction in the Food and Drug Administration’s Mini-Sentinel program. Pharmacoepidemiol Drug Saf. 2013;22(1):40–54. doi:10.1002/pds.3310
  • Ammann EM, Schweizer ML, Robinson JG, et al. Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. Pharmacoepidemiol Drug Saf. 2018;27(4):398–404. doi:10.1002/pds.4398
  • Yih WK, Greene SK, Zichittella L, et al. Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females. Vaccine. 2016;34(1):172–178. doi:10.1016/j.vaccine.2015.09.087
  • Ammann EM, Cuker A, Carnahan RM, et al. Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. Medicine. 2018;97(8):e9960. doi:10.1097/MD.0000000000009960
  • Burn E, Li X, Kostka K, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf. 2022;31(5):495–510. doi:10.1002/pds.5419
  • Madigan D, Ryan PB, Schuemie M, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013;178(4):645–651. doi:10.1093/aje/kwt010
  • Pottegard A, Kurz X, Moore N, Christiansen CF, Klungel O. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. Pharmacoepidemiol Drug Saf. 2020;29(8):825–831. doi:10.1002/pds.5029
  • UK Health Security Agency. Coronavirus (COVID-19) in the UK; 2023. Available from: https://coronavirus.data.gov.uk/details/cases?areaType=nation&areaName=England. Accessed July 16, 2023.
  • Catala M, Coma E, Alonso S, et al. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: a cohort study and ecological analysis. Front Public Health. 2022;10:961030. doi:10.3389/fpubh.2022.961030
  • Xie J, Prats-Uribe A, Feng Q, et al. Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. JAMA Intern Med. 2022;182(10):1063–1070. doi:10.1001/jamainternmed.2022.3858
  • Mercadé-Besora N, Li X, Kolde R, et al. The role of COVID-19 vaccines in preventing post COVID-19 thromboembolic and cardiovascular complications: a multinational cohort study; 2023. Available from: https://www.medrxiv.org/content/10.1101/2023.06.28.23291997v1. Accessed August 29, 2023.
  • World Health Organization. WHO coronavirus (COVID-19) Dashboard; 2023. Available from: https://covid19.who.int/data. Accessed August 9, 2023.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.